Letter to the Editors: Concerning "Divergent clinical outcomes of alpha-glucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state" by Takashi et al. and Letter to the Editors by Ortolano et al. - Research portal of Justus Liebig University Giessen:

Journal article

Letter to the Editors: Concerning "Divergent clinical outcomes of alpha-glucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state" by Takashi et al. and Letter to the Editors by Ortolano et al.

Authors list: Schaenzer, Anne; Giese, Kerstin; Viergutz, Lara; Hahn, Andreas

Publication year: 2017

Pages: 33-34

Journal: Molecular Genetics and Metabolism Reports

Volume number: 12

ISSN: 2214-4269

Open access status: Gold

DOI Link: https://doi.org/10.1016/j.ymgmr.2017.05.005

Publisher: Elsevier

Citation Styles

Harvard Citation style: Schaenzer, A., Giese, K., Viergutz, L. and Hahn, A. (2017) Letter to the Editors: Concerning "Divergent clinical outcomes of alpha-glucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state" by Takashi et al. and Letter to the Editors by Ortolano et al., Molecular Genetics and Metabolism Reports, 12, pp. 33-34. https://doi.org/10.1016/j.ymgmr.2017.05.005

APA Citation style: Schaenzer, A., Giese, K., Viergutz, L., & Hahn, A. (2017). Letter to the Editors: Concerning "Divergent clinical outcomes of alpha-glucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state" by Takashi et al. and Letter to the Editors by Ortolano et al.. Molecular Genetics and Metabolism Reports. 12, 33-34. https://doi.org/10.1016/j.ymgmr.2017.05.005

SDG Areas

3 Good health and well-being